Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boston, MA
NPI
1881641512
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
Zero Emerson Place, Suite 112 Massachusetts General Hospital - Neuroendocri
Boston, MA, 02114
Phone (617) 726-7948
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
387 services
Medicare patients, 2024
263
Average age 69
Drug cost, 2024
$1.3M
1,482 prescriptions
Company payments, 2025
$3,800
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas A Tritos was code 99215 (office e&m - established), 251 times for 221 patients. In total Nicholas A Tritos billed 387 services in 8 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 251 | 221 | $108.66 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 42 | 42 | $13.49 | $567 |
| 99215 Office E&M - Established | Office | 26 | 24 | $144.35 | $3,753 |
| 99443 Telephone Services | Facility | 16 | 13 | $76.23 | $1,220 |
| 99214 Office E&M - Established | Office | 11 | 11 | $108.71 | $1,196 |
| 99221 Hospital E&M - Initial | Facility | 11 | 11 | $62.37 | $686 |
By year: 2022 $78K for 1,169 services; 2023 $34K for 320 services; 2024 $36K for 387 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas A Tritos prescribed most often to Medicare patients was Levothyroxine Sodium, with 378 prescriptions and refills. In total Nicholas A Tritos wrote 1,482 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 378 | 963 | 97 | $3,756 |
| Prednisone Generic | 214 | 412 | 50 | $2,827 |
| Testosterone Generic | 210 | 219 | 36 | $26K |
| Cabergoline Generic | 112 | 248 | 28 | $8,881 |
| Hydrocortisone Generic | 85 | 147 | 18 | $3,246 |
| Testosterone Cypionate Generic | 81 | 84 | 15 | $1,644 |
| Genotropin Somatropin | 60 | 64 | Under 11 | $83K |
| Norditropin Flexpro Somatropin | 29 | 29 | Under 11 | $39K |
| Desmopressin Acetate Generic | 25 | 66 | Under 11 | $2,499 |
| Omnitrope Somatropin | 25 | 25 | Under 11 | $37K |
| Fludrocortisone Acetate Generic | 25 | 59 | Under 11 | $521 |
| Synthroid Levothyroxine Sodium | 24 | 70 | Under 11 | $2,667 |
| Alendronate Sodium Generic | 24 | 62 | Under 11 | $197 |
| Desmopressin Acetate Desmopressin (Nonrefrigerated) | 19 | 40 | Under 11 | $6,208 |
| Somatuline Depot Lanreotide Acetate | 18 | 18 | Under 11 | $119K |
Brand drugs: - claims; generic drugs: 1,037 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas A Tritos $3,800 (- in general payments such as food, travel and fees and $3,800 for research) from 1 company. The largest payer was Pfizer Inc. with $3,800.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 2 | $3,800 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.